Solvay Partners with French Start-Up Ostium in Single-Use Surgical Instruments Material Recycling

Value chain collaboration aims to foster a circular ecosystem and reduce the carbon footprint of single-use surgical instruments molded in Ixef® PARA

Solvay, a leading supplier of advanced materials, has teamed up with French start-up Ostium in a joint project designed to enable the mechanical recycling of end-of-life single-use surgical instruments molded in glass-fiber reinforced Ixef® polyarylamide (PARA) from Solvay’s portfolio of specialty polymers.

The initiative is the first for valuable polymers to be recycled and upcycled from used healthcare devices, proving that the medical safety provided by high-performance polymers such as Solvay’s Ixef® PARA in single-use surgical instruments, can be reconciled with the need for greater sustainability and resource efficiency.

“Our customers in the healthcare industry must meet strict regulatory demands, while at the same time striving to minimize the carbon footprint of their products and support the reduction of hospitals and clinics’ end-of-life waste,” says Claire Guerrero, Global Marketing Manager Sustainability at Solvay. “We identified a gap between these challenges, which prompted us to forge this unique collaboration for developing a breakthrough recycling process for used surgical instruments that are commonly disposed of by incineration rather than reclaiming their high material value. By controlling every step in the loop from the original Ixef® PARA to the upcycled PARA compound, we will be able to ensure its high quality, purity, and performance for demanding downstream applications and can make a significant contribution to a more sustainable polymer economy.”

Ostium Group, a French start-up specializing in the design and manufacture of instruments for hip, knee, shoulder, and trauma orthopedic surgery, will supply hospitals with new custom surgical kits made with Ixef® PARA and collect the contaminated instruments after use. This will also promote the replacement of metal surgical instruments with lightweight polymer designs and help medical facilities reduce their time and cost for sterilization, and disposal as well as lower their carbon footprint.

The partnership with a regionally recognized leader in the treatment and recycling of waste from healthcare activities with infectious risks, was key to developing a dedicated mechanical process to clean, sort, and grind the collected material, delivering high-quality polymer feedstock that can be used in the production of new polymers. In this way, end-of-life surgical instruments can become part of a circular ecosystem that prevents the loss of valuable material and reduces the consumption of fossil resources.

Finally, Solvay is evaluating upcycling options and how to integrate back this recycled feedstock into new high-performance PARA compounds. Initial trials have shown that the recycle-based PARA compound provides a very high level of performance, with up to 85% of flexural properties and no loss in excellent surface appearance when compared with the virgin grade, with the additional advantage of a lower carbon footprint.

In view of regulations in place in the healthcare market with constraints on the use of recycled materials, Solvay is targeting open-loop downstream solutions in which the recycled material will find a second life in high-end markets such as automotive and sports and leisure equipment.

You can find out more about this partnership by visiting Solvay at the COMPAMED 2022 in Düsseldorf, from November 14-17 in Hall 8A, Booth L12.

Ixef® is a registered trademark of Solvay.

SourceSolvay

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version